Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001140361-24-025016
Filing Date
2024-05-09
Accepted
2024-05-08 21:23:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 5711253
2 filename2.htm EX-5.1 37636
3 filename3.htm EX-21.1 6572
4 logo_telix.jpg GRAPHIC 36490
5 ny20018048x7_ex5-1img01.jpg GRAPHIC 96571
6 ny20018048x7_graphic01.jpg GRAPHIC 406134
  Complete submission text file 0001140361-24-025016.txt   6498819
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07070 | Film No.: 24928212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)